Central Trust Company’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Central Trust Company’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7	Closed	-$1K	–	1449
2022 Q2	$1K	Hold	7	–	–	﹤0.01%	1347
2022 Q1	$0	Sell	7 -93	-93%	-$3.13K	﹤0.01%	1534
2021 Q4	$5K	Hold	100	–	–	﹤0.01%	1148
2021 Q3	$7K	Hold	100	–	–	﹤0.01%	1089
2021 Q2	$8K	Buy	+100	New	+$7.39K	﹤0.01%	1057

Central Trust Company's TPTX Position: Q3 2022 in Review

Central Trust Company sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 7 shares — an estimated $1K sold.

Central Trust Company first reported a position in TPTX in Q2 2021 and held it in 5 quarters. The position peaked at $8K in Q2 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Central Trust Company reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Central Trust Company sold 7 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1K.
Central Trust Company first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Central Trust Company's Turning Point Therapeutics, Inc. Common Stock position peaked at $8K in Q2 2021.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Central Trust Company's 13F filing for Q3 2022, filed 3 Nov 2022.